piracetam has been researched along with Sclerosis in 5 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Sclerosis: A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In Group B, LEV was given at 420 mg/ml for the first 2 weeks followed by doubling the dosage (840 mg/ml) in the following 2 weeks." | 5.37 | Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats. ( Arita, K; Hanaya, R; Kumafuji, K; Kurisu, K; Sasa, M; Serikawa, T; Sugata, S; Tokudome, M, 2011) |
| " In Group B, LEV was given at 420 mg/ml for the first 2 weeks followed by doubling the dosage (840 mg/ml) in the following 2 weeks." | 1.37 | Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats. ( Arita, K; Hanaya, R; Kumafuji, K; Kurisu, K; Sasa, M; Serikawa, T; Sugata, S; Tokudome, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palleria, C | 1 |
| Coppola, A | 1 |
| Citraro, R | 1 |
| Del Gaudio, L | 1 |
| Striano, S | 1 |
| De Sarro, G | 1 |
| Russo, E | 1 |
| Caminiti, F | 1 |
| De Salvo, S | 1 |
| Nunnari, D | 1 |
| Bramanti, P | 1 |
| Ciurleo, R | 1 |
| Granata, F | 1 |
| Marino, S | 1 |
| van Vliet, EA | 1 |
| Aronica, E | 1 |
| Redeker, S | 1 |
| Boer, K | 1 |
| Gorter, JA | 1 |
| Sugata, S | 1 |
| Hanaya, R | 1 |
| Kumafuji, K | 1 |
| Tokudome, M | 1 |
| Serikawa, T | 1 |
| Kurisu, K | 1 |
| Arita, K | 1 |
| Sasa, M | 1 |
| Mula, M | 1 |
| Sander, JW | 1 |
| Trimble, MR | 1 |
1 review available for piracetam and Sclerosis
| Article | Year |
|---|---|
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.
Topics: Acetamides; Anticonvulsants; Carbamates; Clinical Trials as Topic; Dibenzazepines; Epilepsy, Tempora | 2015 |
4 other studies available for piracetam and Sclerosis
| Article | Year |
|---|---|
Effect of the antiepileptic therapy on olfactory disorders associated with mesial temporal sclerosis.
Topics: Anticonvulsants; Electroencephalography; Evoked Potentials; Female; Hippocampus; Humans; Levetiracet | 2016 |
Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
Topics: Adolescent; Adult; Animals; Anticonvulsants; Blotting, Western; Child; Disease Models, Animal; Epile | 2009 |
Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats.
Topics: Animals; Anticonvulsants; Brain-Derived Neurotrophic Factor; Hippocampus; Levetiracetam; Neurons; Ne | 2011 |
The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam.
Topics: Adult; Anticonvulsants; Cognition Disorders; Depression; Epilepsy, Temporal Lobe; Female; Hippocampu | 2006 |